tiprankstipranks
Trending News
More News >
Sanofi’s New Phase 2 Study: A Potential Game-Changer in Multiple Myeloma Treatment
PremiumCompany AnnouncementsSanofi’s New Phase 2 Study: A Potential Game-Changer in Multiple Myeloma Treatment
4d ago
Sanofi’s TZIELD® Study: Long-term Safety Insights for Type 1 Diabetes
Premium
Company Announcements
Sanofi’s TZIELD® Study: Long-term Safety Insights for Type 1 Diabetes
4d ago
Sanofi’s Gene Therapy Trial for PKU: A Market Game Changer?
Premium
Company Announcements
Sanofi’s Gene Therapy Trial for PKU: A Market Game Changer?
4d ago
Sanofi’s Teplizumab Study: A New Hope for Japanese Type 1 Diabetes Patients
PremiumCompany AnnouncementsSanofi’s Teplizumab Study: A New Hope for Japanese Type 1 Diabetes Patients
4d ago
Kymera Therapeutics assumed with an Overweight at Morgan Stanley
Premium
The Fly
Kymera Therapeutics assumed with an Overweight at Morgan Stanley
5d ago
Sanofi price target lowered to EUR 115 from EUR 125 at Barclays
Premium
The Fly
Sanofi price target lowered to EUR 115 from EUR 125 at Barclays
5d ago
Sanofi’s Observational Study on Teplizumab: Real-World Insights for Type 1 Diabetes
PremiumCompany AnnouncementsSanofi’s Observational Study on Teplizumab: Real-World Insights for Type 1 Diabetes
5d ago
Sanofi’s Tolebrutinib Study: A New Hope for MS Treatment?
Premium
Company Announcements
Sanofi’s Tolebrutinib Study: A New Hope for MS Treatment?
5d ago
Sanofi’s Riliprubart Gains Orphan Drug Status in US and Japan
Premium
Company Announcements
Sanofi’s Riliprubart Gains Orphan Drug Status in US and Japan
6d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100